Congress Requests Information on Regulation of CBD
On July 27, 2023, a bipartisan group of lawmakers issued a Request for Information (RFI) regarding the regulation of hemp-derived…
Browsing: Cannabinoids
SAMHSA’s Fact Sheet Underscores the Potential Risks of CBD
The rising popularity of cannabidiol (CBD) has ignited conversations about its potential benefits, but SAMHSA’s advisory fact sheet sheds light…
Aimed Alliance’s New Resources on CBD Regulation and Labeling
On Aug. 16, Aimed Alliance published two new resources addressing critical aspects of cannabidiol (CBD) regulation. The Food and Drug…
Congress Requests Information on Regulation of CBD
On July 27, 2023, a bipartisan group of lawmakers issued a Request for Information (RFI) regarding the regulation of hemp-derived…
Primary Care Providers Reluctant to Talk About CBD
Most primary care providers (PCPs) are hesitant to recommend cannabidiol (CBD) products to patients given doubts regarding the products’ safety…
Connecticut Attorney General Shares Concerns on Unregulated Cannabis
The office of the Attorney General recently announced a crackdown on unregulated THC products, like delta-8. Earlier this year, the…
Pennsylvania Court Joins Several States in Requiring Employers to Reimburse Medical Cannabis
On March 17, 2023, the Commonwealth Court of Pennsylvania held, in Fegley v. Firestone Tire & Rubber (Workers’ Comp. Appeal…
DEA Concludes Delta-8 and Delta-9 THC-O are Controlled Substances
On February 13, 2023, the Drug Enforcement Administration (DEA) responded to an inquiry by a North Carolina attorney regarding the…
FDA Announces Need for New Regulatory Pathway for CBD
On January 26, 2023, the Food and Drug Administration (Agency) announced that the existing regulatory frameworks are not appropriate for…
FDA Publishes Final Guidance on Considerations for Clinical Research on Cannabis
On January 23, 2023, the Food and Drug Administration (FDA) published a final guidance for industry, “Cannabis and Cannabis-Derived Compounds:…